Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| ad [2023/07/03 18:25] – [Alzheimer's Disease and Mild Cognitive Impairment] sflitman | ad [2025/05/25 04:35] (current) – [Alzheimer's Disease and Mild Cognitive Impairment] sflitman | ||
|---|---|---|---|
| Line 4: | Line 4: | ||
| ^ Condition(s) ^ Type of Drug ^ Phase ^ Add-On ^ Placebo ^ Duration ^ Open Label Extension ^ | ^ Condition(s) ^ Type of Drug ^ Phase ^ Add-On ^ Placebo ^ Duration ^ Open Label Extension ^ | ||
| - | | MCI and Mild AD | Anti-Tau | + | | MCI and Mild AD | Anti-Tau |
| - | | MCI and Mild AD | Oral Filamin A Stabilizer | + | |
| - | | Mild to Moderate AD | Oral Amyloid Receptor Blocker | + | |
| Also see [[imaging|Imaging]]. | Also see [[imaging|Imaging]]. | ||
| + | < | ||
| + | | MCI and Mild AD | Anti-Tau Intravenous Antibody | ||
| + | < | ||
| ====== Response Form ====== | ====== Response Form ====== | ||
